Literature DB >> 18212817

MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experiment.

Manuela Priolo1, Angela Sparago, Corrado Mammì, Flavia Cerrato, Carmelo Laganà, Andrea Riccio.   

Abstract

Human chromosome 11p15.5 harbours a large cluster of imprinted genes. Different epigenetic defects at this locus have been associated with both Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS). Multiple techniques (Southern blotting, COBRA and microsatellite analysis) have been used so far to detect various DNA methylation abnormalities, uniparental disomies and copy number variations, which are characteristics of these two diseases. We have now evaluated a methylation-specific multiplex-ligation-dependent probe amplification assay (MS-MLPA) for the molecular diagnosis of BWS and SRS. Seventy-three samples derived from BWS- and SRS-affected individuals and 20 controls were analysed by conventional tests and MS-MLPA in blind. All cases that were found positive with conventional methods were also identified by MS-MLPA. These included cases with paternal UPD11, hyper- or hypo-methylation at the Imprinting Centre 1 or Imprinting Centre 2 and rare 11p15.5 duplications. In summary, this MS-MLPA assay can detect both copy number variations and methylation defects of the 11p15.5 critical region within one single experiment and represents an easy, low cost and reliable system for the molecular diagnostics of BWS and SRS.

Entities:  

Mesh:

Year:  2008        PMID: 18212817     DOI: 10.1038/sj.ejhg.5202001

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

1.  Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Licia Peruzzi; Nicoletta Chiesa; Agostina De Crescenzo; Silvia Russo; Daniela Melis; Luigi Tarani; Giuseppina Baldassarre; Lidia Larizza; Andrea Riccio; Margherita Silengo; Giovanni Battista Ferrero
Journal:  Pediatr Nephrol       Date:  2011-10-21       Impact factor: 3.714

2.  Novel deletion of the E3A ubiquitin protein ligase gene detected by multiplex ligation-dependent probe amplification in a patient with Angelman syndrome.

Authors:  Francesco Cali; Alda Ragalmuto; Valeria Chiavetta; Giuseppe Calabrese; Marco Fichera; Mirella Vinci; Giuseppa Ruggeri; Pietro Schinocca; Maurizio Sturnio; Salvatore Romano; Valentino Romano; Maurizio Elia
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

3.  Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes.

Authors:  Amilcar Cordeiro; Ana Paula Neto; Filipa Carvalho; Carla Ramalho; Sofia Dória
Journal:  J Assist Reprod Genet       Date:  2014-07-02       Impact factor: 3.412

4.  (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Silvia Russo; Agostina De Crescenzo; Andrea Freschi; Luciano Calzari; Silvia Maitz; Marina Macchiaiolo; Cristina Molinatto; Giuseppina Baldassarre; Milena Mariani; Luigi Tarani; Maria Francesca Bedeschi; Donatella Milani; Daniela Melis; Andrea Bartuli; Maria Vittoria Cubellis; Angelo Selicorni; Margherita Cirillo Silengo; Lidia Larizza; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

5.  The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases.

Authors:  Nicoletta Chiesa; Agostina De Crescenzo; Kankadeb Mishra; Lucia Perone; Massimo Carella; Orazio Palumbo; Alessandro Mussa; Angela Sparago; Flavia Cerrato; Silvia Russo; Elisabetta Lapi; Maria Vittoria Cubellis; Chandrasekhar Kanduri; Margherita Cirillo Silengo; Andrea Riccio; Giovanni Battista Ferrero
Journal:  Hum Mol Genet       Date:  2011-09-14       Impact factor: 6.150

6.  Addition of H19 'loss of methylation testing' for Beckwith-Wiedemann syndrome (BWS) increases the diagnostic yield.

Authors:  Jochen K Lennerz; Robert J Timmerman; Dorothy K Grange; Michael R DeBaun; Andrew P Feinberg; Barbara A Zehnbauer
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

7.  Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum.

Authors:  Daniela Furlan; Nora Sahnane; Mara Mazzoni; Roberta Pastorino; Ileana Carnevali; Michele Stefanoli; Andrea Ferretti; Anna Maria Chiaravalli; Stefano La Rosa; Carlo Capella
Journal:  Virchows Arch       Date:  2012-12-09       Impact factor: 4.064

8.  Determination of KCNQ1OT1 and H19 methylation levels in BWS and SRS patients using methylation-sensitive high-resolution melting analysis.

Authors:  Marielle Alders; Jet Bliek; Karin vd Lip; Ruud vd Bogaard; Marcel Mannens
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

Review 9.  Genetic considerations in the prenatal diagnosis of overgrowth syndromes.

Authors:  Neeta Vora; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2009-10       Impact factor: 3.050

10.  The cycle of genome-directed medicine.

Authors:  Janet A Buchanan; Andrew R Carson; David Chitayat; David Malkin; M Stephen Meyn; Peter N Ray; Cheryl Shuman; Rosanna Weksberg; Stephen W Scherer
Journal:  Genome Med       Date:  2009-02-02       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.